{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:46:47Z","timestamp":1784728007649,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACYT, Mexico)","award":["INFR-2014-01-226114"],"award-info":[{"award-number":["INFR-2014-01-226114"]}]},{"DOI":"10.13039\/501100007161","name":"SIP, IPN","doi-asserted-by":"publisher","award":["20180198"],"award-info":[{"award-number":["20180198"]}],"id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007161","name":"SIP, IPN","doi-asserted-by":"publisher","award":["20180869"],"award-info":[{"award-number":["20180869"]}],"id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"EDI-IPN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007177","name":"COFAA-IPN programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007177","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejmech.2019.02.028","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T17:36:30Z","timestamp":1549992990000},"page":"402-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation"],"prefix":"10.1016","volume":"167","author":[{"given":"Jos\u00e9 C.","family":"Espinoza-Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Fabiola","family":"Chac\u00f3n-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Hern\u00e1ndez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Nogueda-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Tamariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luvia Enid","family":"S\u00e1nchez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-584X","authenticated-orcid":false,"given":"Alejandro","family":"Camacho-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.02.028_bib1a","series-title":"World Health Organization. Neglected Tropical Diseases. Geneva","author":"WHO","year":"2018"},{"key":"10.1016\/j.ejmech.2019.02.028_bib1b","series-title":"World Health Organization. Chagas Disease (American Trypanosomiasis)","author":"WHO","year":"2018"},{"key":"10.1016\/j.ejmech.2019.02.028_bib2a","series-title":"Drug Discovery for Leishmaniasis","first-page":"3","article-title":"Leishmaniasis, impact and therapeutic Needs","author":"Alvar","year":"2018"},{"key":"10.1016\/j.ejmech.2019.02.028_bib2b","series-title":"Leishmania and Leishmaniasis","author":"Awanish","year":"2013"},{"key":"10.1016\/j.ejmech.2019.02.028_bib2c","series-title":"Trypanosomatid Diseases. Molecular Routes to Drug Discovery","year":"2013"},{"key":"10.1016\/j.ejmech.2019.02.028_bib4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/092986712799828300","article-title":"Leishmaniasis: prevention, parasite detection and treatment","volume":"19","author":"Kobets","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMra1410150","article-title":"Chagas disease","volume":"373","author":"Bern","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.02.028_bib6a","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/0037-8682-0433-2016","article-title":"Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America","volume":"50","author":"Pinheiro","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejmech.2019.02.028_bib6b","series-title":"American Trypanosomiasis Chagas Disease","first-page":"59","article-title":"Current epidemiological trends of chagas disease in Latin america and future challenges: epidemiology, surveillance, and health policies","author":"Moncayo","year":"2017"},{"key":"10.1016\/j.ejmech.2019.02.028_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/138955751503150312122523","article-title":"Drug design for neglected disease in Brazil","volume":"15","author":"Giarolla","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib8","series-title":"Drug Discovery for Leishmaniasis","first-page":"24","article-title":"Anti-leishmanial drug discovery: past, present and future perspectives","author":"Mowbray","year":"2018"},{"key":"10.1016\/j.ejmech.2019.02.028_bib9","unstructured":"reportUNICEF\/UNDP\/World Bank\/WHO Special Program for Research and Training in Tropical Diseases: Joint Coordinating Board (JCB) \u2013 Report on Attendance at JCB in 2017. World Health Organization. http:\/\/www.who.int\/iris\/handle\/10665\/258540."},{"key":"10.1016\/j.ejmech.2019.02.028_bib10","doi-asserted-by":"crossref","first-page":"32376","DOI":"10.1039\/C5RA02669E","article-title":"Antileishmanial drug discovery: comprehensive review of the last 10 years","volume":"5","author":"Jaiprakash","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.02.028_bib11a","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.10.022","article-title":"Leishmania treatment and prevention: natural and synthesized drugs","volume":"160","author":"Bekhit","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib11b","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib12a","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejmech.2018.06.040","article-title":"Current advances in drug discovery for chagas disease","volume":"155","author":"Scarim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib12b","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568026024607427","article-title":"Perspectives for new drugs against trypanosomiasis and leishmaniasis","volume":"2","author":"Barrett","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"220","key":"10.1016\/j.ejmech.2019.02.028_bib13a","first-page":"1","article-title":"Trypanocidal activity of quinoxaline 1,4 di-N-oxide derivatives as trypanothione reductase inhibitors","volume":"22","author":"Chac\u00f3n-Vargas","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.02.028_bib13b","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00436-017-5635-3","article-title":"Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana","volume":"117","author":"Chac\u00f3n-Vargas","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2019.02.028_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1573407211208040002","article-title":"Selected natural and synthetic phenolic compounds with antileishmanial activity: a five-year review","volume":"8","author":"Rojas de Arias","year":"2012","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.ejmech.2019.02.028_bib15","series-title":"The Chemistry of Chalcones and Related Compounds","author":"Nath Dhar","year":"1981"},{"key":"10.1016\/j.ejmech.2019.02.028_bib16","series-title":"Flavonoids. Chemistry, Biochemistry and Applications","author":"\u00d8yvind","year":"2006"},{"key":"10.1016\/j.ejmech.2019.02.028_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/0929867306666220401182509","article-title":"Bioactivities of chalcones","volume":"6","author":"Dimmock","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","article-title":"Recent developments in biological activities of chalcones: a mini review","volume":"85","author":"Parvesh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib19","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.02.028_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejmech.2015.06.052","article-title":"Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives","volume":"101","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/13543776.2014.995627","article-title":"Potential pharmacological uses of chalcones: a patent review","volume":"25","author":"Matos","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.02.028_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijantimicag.2017.06.010","article-title":"The chemotherapeutic potential of chalcones against leishmaniases: a review","volume":"51","author":"Tajuddeen","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.02.028_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.phytochem.2007.01.019","article-title":"Chemistry and pharmacology of oxyprenylated secondary plant metabolites","volume":"68","author":"Epifano","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.02.028_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/092986713804806676","article-title":"Recent trends in the pharmacological activity of isoprenyl phenolics","volume":"20","author":"Mar\u00edn","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.phytochem.2009.08.023","article-title":"Prenylation of aromatic compounds, a key diversification of plant secondary metabolites","volume":"70","author":"Yazaki","year":"2009","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.02.028_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejmech.2014.05.034","article-title":"Synthesis and biological evaluation of chalcones as potential antileishmanial agents","volume":"81","author":"Gupta","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.028_bib27","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.39.12.2742","article-title":"The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria","volume":"39","author":"Zhai","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.02.028_bib28","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.45.7.2023-2029.2001","article-title":"Inhibition of fumarate reductase in L.\u00a0major and L.\u00a0donovani by chalcones","volume":"45","author":"Chen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.02.028_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/43.6.793","article-title":"The antileishmanial activity of novel oxygenated chalcones and their mechanism of action","volume":"43","author":"Zhai","year":"1999","journal-title":"J.\u00a0Antimicrobial Ther."},{"key":"10.1016\/j.ejmech.2019.02.028_bib30","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.bmcl.2015.05.072","article-title":"Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds","volume":"25","author":"Passalacqua","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.028_bib31","series-title":"The Battle against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs","first-page":"564","article-title":"Rational design of new leishmanicidal agents: in silico and in\u00a0vitro evaluation","author":"Andrade Ochoa","year":"2015"},{"key":"10.1016\/j.ejmech.2019.02.028_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12639-014-0569-5","article-title":"In\u00a0vitro efficacy of ethanolic extract of Artemisia absinthium (Asteraceae) against Leishmania major using cell sensitivity and flow cytometry assays","volume":"40","author":"Azizi","year":"2016","journal-title":"J.\u00a0Parasit. Dis."},{"key":"10.1016\/j.ejmech.2019.02.028_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12639-014-0520-9","article-title":"Evaluation of the antileishmanial and cytotoxic effects of various extracts of garlic (Allium sativum)","volume":"40","author":"Mahmoudvand","year":"2016","journal-title":"J.\u00a0Parasit. Dis."},{"key":"10.1016\/j.ejmech.2019.02.028_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/molecules18011053","article-title":"Antiprotozoal activity of quinonemethide triterpenes from maytenusIlicifolia (Celastraceae)","volume":"18","author":"Dos Santos","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.02.028_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-8741(01)00346-4","article-title":"Antiprotozoal activities of colombial plants","volume":"78","author":"Weniger","year":"2001","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.02.028_bib36","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.02.028_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/ci000338c","article-title":"Prediction of drug solubility by the general solubility equation (GSE)","volume":"41","author":"Ran","year":"2001","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T19:55:32Z","timestamp":1662926132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419301424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S0223523419301424"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.028","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}